Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
HIV Infections
Trial Locations (11)

10011

Ricky Hsu, MD, New York

19140

Temple University School of Medicine, Section of Infectious Diseases, Philadelphia

29605

Greenville Hospital System Infectious Disease Associates, Greenville

32803

Orlando Immunology Center, Orlando

48072

Paul Benson, DO, PC, Berkley

60657

Northstar Medical Center, Chicago

75204

Nicholas C. Bellos, MD PA and Associates, Dallas

90022

AltaMed Health Services Corporation, Los Angelos

91356

Shared Medical Research Foundation, Tarzana

Tarzana Treatment Center, Tarzana

93702

Special Services Adult HIV Clinic, Fresno

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Orlando Immunology Center

OTHER